Tubal pregnancy
diseaseOn this page
Also known as ectopic pregnancy of fallopian tubefallopian tube ectopic pregnancyPregnancies, tubaltubal Pregnancies
Summary
Tubal pregnancy (MONDO:0043762) is a disease and 5 clinical trials. Top therapeutic interventions include letrozole. A subtype of ectopic pregnancy — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Clinical trials: 5
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | tubal pregnancy |
| Mondo ID | MONDO:0043762 |
| MeSH | D011274 |
| ICD-11 | 913821868 |
| NCIT | C92946 |
| SNOMED CT | 79586000 |
| UMLS | C0032994 |
| MedGen | 10901 |
| Anatomy (UBERON) | UBERON:0003889 |
| Is cancer (heuristic) | no |
Also known as: ectopic pregnancy of fallopian tube · fallopian tube ectopic pregnancy · Pregnancies, tubal · tubal Pregnancies · tubal pregnancy
Disease family
This is a subtype of ectopic pregnancy. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › reproductive system disorder › female reproductive system disorder › ectopic pregnancy › tubal pregnancy
Related subtypes (3): abdominal ectopic pregnancy, ovarian ectopic pregnancy, pregnancy, cornual
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 5.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 3 |
| PHASE4 | 1 |
| PHASE3 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT00137982 | PHASE4 | UNKNOWN | Evaluation of Therapeutic Strategies for Treatment of Ectopic Pregnancies (EP) and Evaluation of Subsequent Fertility |
| NCT04341545 | PHASE3 | UNKNOWN | Letrozole in Tubal Ectopic Pregnancy |
| NCT05498558 | Not specified | UNKNOWN | The Selection of Pregnancy for Patients After Tubal Ectopic Pregnancy Treatment |
| NCT05591599 | Not specified | UNKNOWN | Diagnostic Value of Calponin 2 in Identifying Tubal Pregnancies |
| NCT06426979 | Not specified | COMPLETED | Sequential Letrozole and Methotrexate Therapy Role in Treatment of Tubal Ectopic Pregnancy |
Drugs tested across these trials (top 30)
| Molecule | Max phase | Trials referencing |
|---|---|---|
| LETROZOLE | 4 | 2 |
Related Atlas pages
- Drugs: Letrozole